Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/07/2895293/0/en/Y-mAbs-Announces-Preclinical-GD2-SADA-Data-to-be-Presented-at-2024-SNMMI-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/06/05/2893751/0/en/Y-mAbs-Deepens-Radiopharmaceutical-Leadership-with-Appointment-of-Norman-LaFrance-M-D-as-Chief-Development-Officer.html
https://www.globenewswire.com/news-release/2024/06/01/2891816/0/en/Y-mAbs-Announces-Publication-of-Preclinical-GD2-SADA-Data-at-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/06/01/2891814/0/en/Y-mAbs-Announces-New-Interim-Analysis-of-Phase-2-Data-for-Naxitamab-at-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/07/2877228/0/en/Y-mAbs-Reports-First-Quarter-2024-Financial-Results-and-Recent-Corporate-Developments.html
https://www.globenewswire.com/news-release/2024/04/26/2870387/0/en/Y-mAbs-to-Announce-First-Quarter-2024-Financial-and-Operating-Results-on-May-7-2024.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761171
https://www.globenewswire.com//news-release/2024/03/14/2846337/0/en/Y-mAbs-Therapeutics-Announces-Resignation-of-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2024/03/04/2839442/0/en/Y-mAbs-Appoints-Oncology-Executive-Mary-Tagliaferri-M-D-to-its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/02/29/2838407/0/en/Y-mAbs-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Corporate-Developments.html